The mean length of the preclinical detectable phase (PCDP) of open-angle glaucoma is estimated to be over 10 years, according to a study published online Nov. 23 in JAMA Ophthalmology.
Nov 29, 2022
0
2
In a finding that suggests more Americans than ever are struggling with their sight as they get older, researchers report that nearly 20 million adults have age-related macular degeneration (AMD).
Nov 4, 2022
0
15
In most U.S. counties, a Google search of the phrase "eye doctor near me" may underrepresent ophthalmologists, according to a study published online Oct. 20 in JAMA Ophthalmology.
Oct 26, 2022
0
32
Among ophthalmologic residents, there are no differences across performance metrics between residents taking parental leave versus their peers not taking leave, according to a study published online Sept. 29 in JAMA Ophthalmology.
Oct 5, 2022
0
4
Adolescent children who are Black, Mexican, low-income, or non-U.S. citizens are more likely to report poor subjective visual function and worse performance on visual acuity testing, according to a study published online ...
Sep 19, 2022
0
4
Visual acuity (VA) is better when tested in the clinic versus at home, according to a research letter published online Aug. 18 in JAMA Ophthalmology.
Aug 25, 2022
0
4
In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical ...
Aug 15, 2022
0
82
COVID-19 vaccine initiation is lower among adults with vision or hearing disabilities compared with adults without disabilities, according to a study published online Aug. 11 in JAMA Ophthalmology.
Aug 12, 2022
0
11
There is considerable variation in county-level prevalence of visual acuity or blindness, with a positive correlation between visual acuity loss or blindness and the percentage of the population living below the poverty level, ...
Jul 8, 2022
0
2
For patients with neovascular age-related macular degeneration (nAMD), ranibizumab with a port delivery system (PDS) with one refill costs more than intravitreal ranibizumab or aflibercept injections if about 11 or 10 injections, ...
Jun 23, 2022
0
2
